Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ProVIDE II Bridging Study

NCT: NCT06236802 · ACTIVE_NOT_RECRUITING

NCT IDNCT06236802
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-06
Completion2029-06-01
SponsorProVerum Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑